NCT05199818 2023-01-20
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
Xiamen LP Pharmaceutical Co., Ltd
Phase 3 Unknown
Xiamen LP Pharmaceutical Co., Ltd
ChineseAMS
Zhejiang University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano